- Home
- AVXL vs PDM Comparison
AVXL vs PDM Comparison
Compare AVXL & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- PDM
- Stock Information
- Founded
- AVXL 2004
- PDM 1997
- Country
- AVXL United States
- PDM United States
- Employees
- AVXL N/A
- PDM N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- PDM Building operators
- Sector
- AVXL Health Care
- PDM Real Estate
- Exchange
- AVXL Nasdaq
- PDM Nasdaq
- Market Cap
- AVXL 956.7M
- PDM 1.1B
- IPO Year
- AVXL N/A
- PDM N/A
- Fundamental
- Price
- AVXL $9.80
- PDM $8.59
- Analyst Decision
- AVXL Strong Buy
- PDM Buy
- Analyst Count
- AVXL 2
- PDM 5
- Target Price
- AVXL $44.00
- PDM $9.40
- AVG Volume (30 Days)
- AVXL 1.2M
- PDM 864.9K
- Earning Date
- AVXL 08-12-2025
- PDM 10-23-2025
- Dividend Yield
- AVXL N/A
- PDM 2.90%
- EPS Growth
- AVXL N/A
- PDM N/A
- EPS
- AVXL N/A
- PDM N/A
- Revenue
- AVXL N/A
- PDM $565,502,000.00
- Revenue This Year
- AVXL N/A
- PDM $0.09
- Revenue Next Year
- AVXL N/A
- PDM N/A
- P/E Ratio
- AVXL N/A
- PDM N/A
- Revenue Growth
- AVXL N/A
- PDM N/A
- 52 Week Low
- AVXL $5.03
- PDM $5.46
- 52 Week High
- AVXL $14.44
- PDM $11.12
- Technical
- Relative Strength Index (RSI)
- AVXL 58.71
- PDM 49.43
- Support Level
- AVXL $8.80
- PDM $8.67
- Resistance Level
- AVXL $10.04
- PDM $9.03
- Average True Range (ATR)
- AVXL 0.49
- PDM 0.21
- MACD
- AVXL 0.18
- PDM -0.07
- Stochastic Oscillator
- AVXL 73.79
- PDM 0.00
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.